AlphavirusAntibodies, MonoclonalApoptosis
Maurizio Bendandi
NPI1508222720
- Medicare services, 2021
- 106
- Part D claims, 2020
- 80
- Publications
- 16
- Clinical trials
- 1
- Industry payments
- $1,289
- Practice address
- 3506 West Tyvola Road, Charlotte, NC 28208
- Practice phone
- Call (704) 329-1300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
South Charlotte VA Clinic
Outpatient Addiction Treatment · Charlotte, North Carolina
Find Maurizio Bendandi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Maurizio Bendandi is a hematologist and oncologist in Charlotte, North Carolina
Maurizio Bendandi practices at South Charlotte VA Clinic in Charlotte, North Carolina.
Maurizio Bendandi's NPI, 1508222720, was assigned on January 4, 2016. Maurizio Bendandi holds North Carolina license 2016-01868.
NPI and contact details
- NPI
- 1508222720NPI Registry (opens in a new tab)
- NPI enumeration date
- January 4, 2016
- NPI status
- Active
- Practice phone
- (704) 329-1300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Maurizio Bendandi practices at South Charlotte VA Clinic in Charlotte, North Carolina
Maurizio Bendandi's primary practice is South Charlotte VA Clinic, at 3506 West Tyvola Road, Charlotte, NC 28208. The practice phone is (704) 329-1300.
- South Charlotte VA Clinic3506 West Tyvola Road, Charlotte, NC 28208Phone(704) 329-1300
Source: Dmand AI Affiliation Data
Maurizio Bendandi is affiliated with 3 sites of care and 1 medical group
Maurizio Bendandi's primary practice is South Charlotte VA Clinic in Charlotte, North Carolina. Dmand AI also links Maurizio Bendandi to 1 government or correctional health site, 1 group practice or clinic and 1 medical group, each named with a free account. Maurizio Bendandi's employer is on file too: a behavioral health center.
South Charlotte VA ClinicPrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Maurizio Bendandi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Maurizio Bendandi practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| South Charlotte VA Clinic | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Maurizio Bendandi practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Maurizio Bendandi is one of 420 hematologists and oncologists in North Carolina
Hematology and oncology is Maurizio Bendandi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Maurizio Bendandi is licensed in North Carolina.
Specialties and state licenses
- Hematology and oncology, North CarolinaPrimary
Hematologists and oncologists near Maurizio Bendandi
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Maurizio Bendandi billed Medicare for 106 services in 2021
CMS data shows 106 Medicare services from Maurizio Bendandi across 2 procedure codes in 2021, all of them office visits. Medicare paid $10,713 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2021106
Paid by Medicare$10,713
Procedure codes2
Maurizio Bendandi's Medicare services by type, 2020 to 2021
- 2020
- 2021
- Office and hospital visits
- 2020: 2162021: 10651%
Maurizio Bendandi compared with the North Carolina median for hematologists and oncologists, 2021
- Maurizio Bendandi
- North Carolina median
- Medicare services
- 106vs 45076% below
- Part D claims
- 80vs 32475% below
Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.
Maurizio Bendandi's most billed Medicare procedure codes, 2021
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Maurizio Bendandi?
Medicare shows one payer. Book a meeting to get commercial claims data for Maurizio Bendandi and other hematologists and oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Maurizio Bendandi's patients have a median age of 68
Across all payers, Dmand AI patient panel data puts Maurizio Bendandi's median patient age at 68, with 25% women.
Maurizio Bendandi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women25%
- Men75%
Source: Dmand AI Patient Panel Data
Maurizio Bendandi wrote 80 Medicare Part D claims in 2020
In 2020, Maurizio Bendandi wrote 80 Medicare Part D claims. They cover 4 drugs, with $520,074 in total drug cost. In 2019, CMS named 102 claims across 6 drugs.
Part D claims, 202080
Drugs named by CMS4
Total drug cost$520,074
Maurizio Bendandi's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 1022020: 8022%
Drugs named by CMS: 4 in 2020, 6 in 2019.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Maurizio Bendandi by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Maurizio Bendandi has 16 publications on record
Dmand AI links 16 papers to Maurizio Bendandi, published from 2011 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Aptamers, Nucleotide, Cancer Vaccines and Vaccination. Maurizio Bendandi has published most often in Biomaterials. Maurizio Bendandi's most frequent co-authors are Tamjeed Ahmed, MD, Weiyun Z. Ai, MD and Robert Howard Collins, MD.
Papers16
Years published2011 to 2021
Maurizio Bendandi's papers by year, 2011 to 2021
Topics Maurizio Bendandi writes about most
- Aptamers, Nucleotide
- Cancer Vaccines
- Vaccination
- Cell Proliferation
- Immunoglobulin Idiotypes
- Lymphocyte Activation
- Mice, Inbred BALB C
- SELEX Aptamer Technique
Maurizio Bendandi's most frequent co-authors
- Tamjeed Ahmed, MD1 shared paper
- Weiyun Z. Ai, MD1 shared paper
- Robert Howard Collins, MD1 shared paper
Recent publications by Maurizio Bendandi
Brain NeoplasmsPlasma CellsRadiosurgery
Amino Acid MotifsAntigens, CDAptamers, Nucleotide
Brain NeoplasmsChemoradiotherapyCytokines
Aptamers, NucleotideCancer VaccinesCD28 Antigens
See who Maurizio Bendandi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Maurizio Bendandi works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Maurizio Bendandi has worked on 1 clinical trial
Dmand AI links Maurizio Bendandi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lymphoma, B-Cell, Marginal Zone and Lymphoma, Mantle-Cell. Open Payments lists research payments to Maurizio Bendandi that name 1 trial.
Conditions in Maurizio Bendandi's trials
- Lymphoma, B-Cell, Marginal Zone
- Lymphoma, Mantle-Cell
Investigators on the most trials with Maurizio Bendandi
- Jon Eric Arnason, MD1 shared trial
- Sabarish R. Ayyappan, MD1 shared trial
- Deirdre M. Coll, MD1 shared trial
Recent clinical trials with Maurizio Bendandi
$1,396 in research paymentsLymphoma, B-Cell, Marginal ZoneLymphoma, Mantle-CellOdronextamab
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Maurizio Bendandi received $1,289 in industry payments from 2016 to 2025
CMS Open Payments shows 15 general payments to Maurizio Bendandi from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Bristol-Myers Squibb Company paid the most, $362. It also lists 6 research payments totaling $1,396 in 2019, naming 1 clinical trial.
General payments to Maurizio Bendandi by program year, 2016 to 2025
General payments to Maurizio Bendandi by kind, 2016 to 2025
$1.3Kin total
- Food and beverage$1,07583%
- Travel and lodging$20216%
- Education$121%
Companies that paid Maurizio Bendandi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Maurizio Bendandi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Maurizio Bendandi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Maurizio Bendandi's NPI number?
Maurizio Bendandi's NPI number is 1508222720. It was assigned on January 4, 2016, and it is active in the NPI Registry.
What does Maurizio Bendandi specialize in?
Maurizio Bendandi is a hematologist and oncologist in Charlotte, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Maurizio Bendandi practice?
Maurizio Bendandi practices at 3506 West Tyvola Road, Charlotte, NC 28208. Maurizio Bendandi's primary practice is South Charlotte VA Clinic in Charlotte, North Carolina. Dmand AI also links Maurizio Bendandi to 1 government or correctional health site, 1 group practice or clinic and 1 medical group.
What is Maurizio Bendandi's office phone number?
The practice phone on file for Maurizio Bendandi is (704) 329-1300.
What is Maurizio Bendandi's medical license number?
Maurizio Bendandi holds North Carolina license 2016-01868.
Does Maurizio Bendandi accept Medicare?
Yes. CMS data shows Maurizio Bendandi billed Medicare for 106 services in 2021.
What services does Maurizio Bendandi bill to Medicare?
In 2021, Maurizio Bendandi's most billed Medicare services were office visit, established patient (99215) and office visit, new patient (99205).
What drugs does Maurizio Bendandi prescribe most?
In 2020 Medicare Part D data, Maurizio Bendandi's most prescribed drugs by claims were Calquence, Acyclovir and Imbruvica.
Has Maurizio Bendandi received payments from drug or device companies?
CMS Open Payments shows $1,289 in general payments to Maurizio Bendandi from 9 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Maurizio Bendandi been practicing?
Maurizio Bendandi's NPI was assigned in 2016.
Does Maurizio Bendandi do research?
Dmand AI links 16 publications to Maurizio Bendandi, published from 2011 to 2021. Maurizio Bendandi has worked on 1 clinical trial.
Who does Maurizio Bendandi publish with?
Maurizio Bendandi's most frequent co-authors are Tamjeed Ahmed, MD (1 shared paper), Weiyun Z. Ai, MD (1 shared paper) and Robert Howard Collins, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card